113 related articles for article (PubMed ID: 12426658)
1. Treatment of tendopathies with tropisetron.
Stratz T; Varga B; Müller W
Rheumatol Int; 2002 Nov; 22(6):219-21. PubMed ID: 12426658
[TBL] [Abstract][Full Text] [Related]
2. Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron.
Müller W; Stratz T
Scand J Rheumatol Suppl; 2004; 119():44-8. PubMed ID: 15515413
[TBL] [Abstract][Full Text] [Related]
3. Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone.
Samborski W; Stratz T; Mackiewicz S; Müller W
Scand J Rheumatol Suppl; 2004; 119():51-4. PubMed ID: 15515415
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.
Späth M; Stratz T; Neeck G; Kötter I; Hammel B; Amberger CC; Haus U; Färber L; Pongratz D; Müller W
Scand J Rheumatol; 2004; 33(4):267-70. PubMed ID: 15370724
[TBL] [Abstract][Full Text] [Related]
5. Local treatment of tendinopathies: a comparison between tropisetron and depot corticosteroids combined with local anesthetics.
Stratz Th; Färber L; Müller W
Scand J Rheumatol; 2002; 31(6):366-70. PubMed ID: 12492253
[TBL] [Abstract][Full Text] [Related]
6. Fibromyalgia treatment with intravenous tropisetron administration.
Stratz T; Färber L; Varga B; Baumgartner C; Haus U; Müller W
Drugs Exp Clin Res; 2001; 27(3):113-8. PubMed ID: 11447769
[TBL] [Abstract][Full Text] [Related]
7. [Local treatment of periarthropathies with the 5-HT3-receptor-antagonist tropisetron].
Stratz T; Stauber A; Müller W
Z Orthop Ihre Grenzgeb; 2002; 140(4):394-8. PubMed ID: 12183788
[TBL] [Abstract][Full Text] [Related]
8. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.
Pickering G; Loriot MA; Libert F; Eschalier A; Beaune P; Dubray C
Clin Pharmacol Ther; 2006 Apr; 79(4):371-8. PubMed ID: 16580905
[TBL] [Abstract][Full Text] [Related]
9. [Local treatment of rheumatic diseases with the 5-HT3 receptor antagonist tropisetron].
Stratz T; Müller W
Schmerz; 2003 Jun; 17(3):200-3. PubMed ID: 12789487
[TBL] [Abstract][Full Text] [Related]
10. [5-HT3 receptor antagonist als analgetics in rheumatic diseases].
Müller W; Fiebich BL; Stratz T
Z Rheumatol; 2006 Oct; 65(6):546, 548-52. PubMed ID: 16450149
[TBL] [Abstract][Full Text] [Related]
11. The 5-HT3 blockers in the treatment of the primary fibromyalgia syndrome: a 10-day open study with Tropisetron at a low dose.
Samborski W; Stratz T; Lacki JK; Klama K; Mennet P; Müller W
Mater Med Pol; 1996; 28(1):17-9. PubMed ID: 9088121
[TBL] [Abstract][Full Text] [Related]
12. Trigger point injection treatment with the 5-HT3 receptor antagonist tropisetron in patients with late whiplash-associated disorder. First results of a multiple case study.
Ettlin T
Scand J Rheumatol Suppl; 2004; 119():49-50. PubMed ID: 15515414
[TBL] [Abstract][Full Text] [Related]
13. Do cytochrome enzymes influence the therapeutic effect of tropisetron in fibromyalgia?
Stratz T; Kees F; Müller W
Drugs Exp Clin Res; 2003; 29(2):91-4. PubMed ID: 12951840
[TBL] [Abstract][Full Text] [Related]
14. Topical anesthesia with EMLA reduces pain during endomyocardial biopsy: a randomized trial.
Leloudis DH; Kittleson MM; Felker GM; Rosenberg PB; Hernandez AF; Yager JE; Russell SD
J Heart Lung Transplant; 2006 Sep; 25(9):1164-6. PubMed ID: 16962481
[TBL] [Abstract][Full Text] [Related]
15. [Pilot study with 5-HT3 antagonists. Good outcome in fibromyalgia pain].
Stratz T; Müller W
MMW Fortschr Med; 2002 Mar; 144(11):49. PubMed ID: 12066514
[No Abstract] [Full Text] [Related]
16. Results of the intravenous administration of tropisetron in fibromyalgia patients.
Müller W; Stratz T
Scand J Rheumatol Suppl; 2000; 113():59-62. PubMed ID: 11028834
[TBL] [Abstract][Full Text] [Related]
17. Double-blind crossover study with dolasetron mesilate, a 5-HT3 receptor antagonist in cerebellar syndrome secondary to multiple sclerosis.
Monaca-Charley C; Stojkovic T; Duhamel A; De Seze J; Ferriby D; Vermersch P
J Neurol; 2003 Oct; 250(10):1190-4. PubMed ID: 14586600
[TBL] [Abstract][Full Text] [Related]
18. Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis.
Voog U; Alstergren P; Leibur E; Kallikorm R; Kopp S
Mediators Inflamm; 2004 Dec; 13(5-6):373-6. PubMed ID: 15770056
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.
Färber L; Stratz T; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Alten R; Müller W
Scand J Rheumatol Suppl; 2000; 113():49-54. PubMed ID: 11028832
[TBL] [Abstract][Full Text] [Related]
20. [Pain modification by the 5-HT3 receptor antagonist tropisetron in secondary fibromyalgias].
Stratz T; Müller W
Fortschr Med Orig; 2002; 120(1):17-20. PubMed ID: 14518353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
